IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.14% | 7.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.14% | 7.03% | |||
| Cost of Revenue | -8.75% | 20.23% | |||
| Gross Profit | -1.28% | 3.26% | |||
| SG&A Expenses | -5.92% | 1.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.49% | 8.56% | |||
| Operating Income | 2.02% | 3.80% | |||
| Income Before Tax | -0.28% | 6.75% | |||
| Income Tax Expenses | 44.67% | -21.64% | |||
| Earnings from Continuing Operations | -9.69% | 15.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.69% | 15.52% | |||
| EBIT | 2.02% | 3.80% | |||
| EBITDA | 2.91% | 3.56% | |||
| EPS Basic | -10.01% | 15.35% | |||
| Normalized Basic EPS | 2.04% | 3.82% | |||
| EPS Diluted | -10.05% | 16.35% | |||
| Normalized Diluted EPS | 2.44% | 3.83% | |||
| Average Basic Shares Outstanding | 0.35% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.12% | |||
| Dividend Per Share | 0.00% | 17.65% | |||
| Payout Ratio | -0.67% | 2.42% | |||